Haloxa 0.05% Cream Cream

About Haloxa 0.05% Cream 50 mg/100 gm

Haloxa 0.05% Cream 50 mg/100 gm cream is a medicine made by Opsonin Pharma Limited. Haloxa 0.05% Cream cream is used to ease the inflammation and itching of skin conditions that respond to corticosteroids.

There are 7 brands of Halobetasol Propionate listed in Bangladesh.

What is Haloxa 0.05% Cream 50 mg/100 gm?

Haloxa 0.05% Cream 50 mg/100 gm is a cream product of Opsonin Pharma Limited that contains Halobetasol Propionate. It is used for the relief of inflammatory and itchy signs of skin conditions that respond to corticosteroids. Do not use it on your own for other skin problems. Use it only as your doctor directs.

Uses of Haloxa 0.05% Cream

Haloxa 0.05% Cream cream is used to ease the inflammation and itching of skin conditions that respond to corticosteroids. It is a super-high potency topical steroid, so it is meant for short-term use under a doctor's supervision. It is a super-high potency topical corticosteroid, so it is meant for conditions that need strong treatment. Your doctor will assess your skin problem and decide whether this medicine is appropriate.

How to use Haloxa 0.05% Cream

Stop and contact your doctor if the skin does not improve within the period your doctor set. Apply Haloxa 0.05% Cream only to the skin, as directed by your doctor. Wash your hands before and after applying it. Keep the medicine out of reach of children. The doctor decides the amount, how often to apply it and how long to continue. If you miss a dose, ask your doctor or pharmacist what to do.

Side effects of Haloxa 0.05% Cream

Some people may notice skin reactions where Haloxa 0.05% Cream is applied. Some people may experience side effects with topical corticosteroids. Your doctor can advise whether to stop the medicine or change the treatment. Tell your doctor or pharmacist if any reaction worries you. Tell your doctor if any side effect bothers you or does not go away.

Safety and precautions

Potent topical steroids can be absorbed through the skin, especially when large amounts are used over large areas or under dressings, so your doctor may check you if you use it this way. Use in pregnancy and while breastfeeding only if your doctor decides the benefit justifies the risk. Haloxa 0.05% Cream is a strong steroid and should only be used on the skin. Keep out of reach of children.

Frequently asked questions

What is Haloxa 0.05% Cream used for?

Haloxa 0.05% Cream cream is used to ease the inflammation and itching of skin conditions that respond to corticosteroids. It is a super-high potency topical steroid, so it is meant for short-term use under a doctor's supervision.

How do I use Haloxa 0.05% Cream correctly?

Stop and contact your doctor if the skin does not improve within the period your doctor set. Apply Haloxa 0.05% Cream only to the skin, as directed by your doctor.

What should I watch for while using Haloxa 0.05% Cream?

Some people may notice skin reactions where Haloxa 0.05% Cream is applied. Some people may experience side effects with topical corticosteroids.

Who should be careful with Haloxa 0.05% Cream?

Potent topical steroids can be absorbed through the skin, especially when large amounts are used over large areas or under dressings, so your doctor may check you if you use it this way. Use in pregnancy and while breastfeeding only if your doctor decides the benefit justifies the risk.

Indications

Halobetasol Propionate 0.05% is a super-high potent corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Treatment beyond two consecutive weeks is not recommended, and the total dosage should not exceed 50 gm/week because of the potential for the drug to suppress the Hypothalamic-Pituitary-Adrenal (HPA) axis.

Pharmacology

Like other topical corticosteroids, halobetasol propionate has anti-inflammatory, antipruritic and vasoconstrictive actions. The mechanism of the anti-inflammatory activity of the topical corticosteroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2 .

Dosage & Administration

Apply a thin layer of Halobetasol Cream or Ointment to the affected skin once or twice daily, as directed by the physician, and rub in gently and completely. Halobetasol 0.05% is a super-high potency corticosteroid; therefore, treatment should be limited to two weeks, and amounts greater than 50 gm/week should not be used. As with other highly active corticosteroids, therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. Halobetasol should not be used with occlusive dressings.

Contraindications

Halobetasol Propionate Cream/Ointment is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Side Effects

The following adverse effects have been reported infrequently with topical corticosteroids. These reactions include burning, itching, dryness, folliculitis acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin atrophy, secondary infections, striae and miliaria.

Pregnancy & Lactation

Topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Therefore caution should be exercised when topical corticosteroids are administered to a nursing woman.

Precautions & Warnings

Systemic absorption of topical corticosteroids may cause reversible Hypothalamic-Pituitary-Adrenal (HPA) axis suppression, manifestations of cushing's syndrome, hyperglycemia, and glucosuria. Patients receiving large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests. If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent steroid.

Storage Conditions

Store below 30°C. Keep all medicines out of reach of children.

Alternative brands of Halobetasol Propionate

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.